Canada has a huge opportunity to advance AMR by putting in place the pan-Canadian AMR plan to make this a program that is a long-lasting program and a collaboration between the industry and all levels of government.
That would bring investments to the antimicrobial space. It would bring investments to Canada. It would bring more clinical trials to Canada. It would create jobs in Canada.
What it requires is really executing on this plan, doing this as fast as possible and engaging in this push-pull incentive: a real collaborative approach between the industry and all levels of government in Canada.